Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEnglewood Hospital and Medical Center

About this trial

the investigators will pursue two specific aims: (1) to monitor the extent of heme oxygenase induction (by measuring endogenous CO production) in relationship to the extent of hepatic resection (2) to assess the production of CO in patients following liver resection and correlate these findings to the rate of liver regeneration and liver function.

Eligibility criteria

Qualifiers

Patient plans to have partial liver resection for primary liver pathology or metastatic disease

Patient is able to comprehend and willing to sign the written consent form

Disqualifiers

Patients < 18 years

Patients identified as members of a vulnerable population, except women of child bearing potential with negative pregnancy test

Trial design

Treatments tested in this trial

  • carbon monoxide measurement via smokerlyzer

Treatment groups

125 Participants
are divided into 1 treatment group